Ozenoxacin cream approved for use in impetigo in infants


eMediNexus    16 December 2017

The US Food and Drug Administration (FDA) has approved ozenoxacin cream 1% for impetigo in patients aged 2 months and older. A quinolone antimicrobial, ozenoxacin cream is to be applied twice daily for 5 days.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.